AHA: More intensive blood pressure lowering cuts future cardiovascular risk after stroke, transient ischemic attack
For adults with previous ischemic stroke or transient ischemic attack, targeting a systolic blood pressure
Nov 13, 2026
0
9
MeSH tree: E05.318.740
For adults with previous ischemic stroke or transient ischemic attack, targeting a systolic blood pressure
Nov 13, 2026
0
9
A new genetic test developed by researchers at QIMR Berghofer and Flinders University, along with international collaborators, can identify people at up to 10 times the normal risk of developing open-angle glaucoma, the most ...
Nov 13, 2026
0
38
New research in the November 2026 issue of Journal of the National Comprehensive Cancer Network found that patients with advanced non-small cell lung cancer (NSCLC) lived longer when they received broad-based genomic sequencing ...
Nov 12, 2026
0
6
A blood test could help identify men with advanced prostate cancer who are more likely to experience longer disease control following targeted radiotherapy, according to research led by The Royal Marsden NHS Foundation Trust, ...
Nov 12, 2026
0
10
An international study reports 60% progression-free survival at 10 years after autologous bone marrow transplantation, adding evidence of sustained positive clinical outcomes and long-term safety in patients treated for early ...
Oct 29, 2026
0
7
Results of a phase 1/2 trial led by Roswell Park Comprehensive Cancer Center show that combining the targeted therapies bevacizumab (Avastin) and pazopanib (Votrient) significantly extends both progression-free and overall ...
Oct 28, 2026
0
8
In a global phase 1 trial, trastuzumab rezetecan showed promising signs of fighting ERBB2-low metastatic breast cancer in patients who had already undergone extensive treatment. Also known as HER2-low breast cancer, this ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer with apalutamide—a next-generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)—plus hormone ...
Oct 26, 2026
0
8
An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic researchers. The ...
Oct 24, 2026
0
115
Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with metastatic castration-resistant prostate cancer (mCRPC) in routine clinical practice, consistent with ...
Oct 23, 2026
0
11